Boone Capital Management »

Bio-Rad Laboratories shares owned by Boone Capital Management

Quarter-by-quarter ownership of Bio-Rad Laboratories (BIO) shares owned by Boone Capital Management from 13F filings

Historical chart of Boone Capital Management investment in Bio-Rad Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Bio-Rad Laboratories held by Boone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-Rad Laboratories by Boone Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 36k 322.89

More positions owned by Boone Capital Management

Unum (UNM)
Colfax Corp (ENOV)
Amgen (AMGN)
CVS Caremark Corporation (CVS)
Globus Med Cl A (GMED)
Cigna Corp (CI)
Danaher Corporation (DHR)
Amphastar Pharmaceuticals (AMPH)
Molina Healthcare (MOH)
Baxter International (BAX)
Viatris (VTRS)
Ideaya Biosciences (IDYA)
Bridgebio Pharma (BBIO)
Berry Plastics (BERY)
Quanterix Ord (QTRX)

View all positions for Boone Capital Management

Top funds holding Bio-Rad Laboratories

Vanguard Group
Veritas Asset Management
Ubs Global Asset Management Americas
Alliancebernstein
Investec Asset Management
Earnest Partners
Bank of America Corporation
Southeastern Asset Management
Thompson, Siegel, & Walmsley
Massachusetts Financial Services
Hound Partners
Westfield Capital Management Company
Parnassus Investments
Norges Bank Investment Management
Millennium Management

View all funds holding Bio-Rad Laboratories